Yea the FDA was right , but not for CyDy , the FDA changes our trial endpoint on our CD-12 but wouldn’t allow us to do the same and what about 3 years after completing our stellar HIV trial , in order to slow us down the FDA ask for RO . How would you not look at that and plainly see the fix was on from the start. Now let’s talk data mining and small subsets for which CyDy has been accused of. What data did they manufacture to say that Remdesivir showed any medical benefit , because the WHO’S 5000 patient trial showed the drug doesn’t work at all . This week you have a drug for Alzheimer’s approved on some small possibly showing benefit maybe trending to show sig. We don’t play by the same rules and only a fool would say otherwise. I’m not an NP fan but guess what there is not a f……..ng thing I can do about at the moment. The FDA follows guidelines when it benefits big pharma thus spilling over to there pockets. CyDy is in need of revenue we knew that going into the investment . With everything going against us and questionable management we are still in position to get LL to the market. All of you pulling so hard to stop this from happening should go ahead and prepare yourself and understand this drug is coming to help despite your efforts.
News 
Market Data 
Discover 
